Cargando…
The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
Bacterial vaginosis (BV), a condition in which the vaginal microbiota consists of community of obligate and facultative anaerobes rather than dominated by a single species of Lactobacillus, affects ~30% of women in the US. Women with BV are at 60% increased risk for HIV acquisition and are 3-times m...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999914/ https://www.ncbi.nlm.nih.gov/pubmed/31971984 http://dx.doi.org/10.1371/journal.ppat.1008236 |
_version_ | 1783493983402459136 |
---|---|
author | Hoang, Thuy Toler, Emily DeLong, Kevin Mafunda, Nomfuneko A. Bloom, Seth M. Zierden, Hannah C. Moench, Thomas R. Coleman, Jenell S. Hanes, Justin Kwon, Douglas S. Lai, Samuel K. Cone, Richard A. Ensign, Laura M. |
author_facet | Hoang, Thuy Toler, Emily DeLong, Kevin Mafunda, Nomfuneko A. Bloom, Seth M. Zierden, Hannah C. Moench, Thomas R. Coleman, Jenell S. Hanes, Justin Kwon, Douglas S. Lai, Samuel K. Cone, Richard A. Ensign, Laura M. |
author_sort | Hoang, Thuy |
collection | PubMed |
description | Bacterial vaginosis (BV), a condition in which the vaginal microbiota consists of community of obligate and facultative anaerobes rather than dominated by a single species of Lactobacillus, affects ~30% of women in the US. Women with BV are at 60% increased risk for HIV acquisition and are 3-times more likely to transmit HIV to an uninfected partner. As cervicovaginal mucus (CVM) is the first line of defense against mucosal pathogens and the home of the resident vaginal microbiota, we hypothesized the barrier function of CVM to HIV may be diminished in BV. Here, we characterized CVM properties including pH, lactic acid content, and Nugent score to correlate with the microbiota community composition, which was confirmed by 16S rDNA sequencing on a subset of samples. We then quantified the mobility of fluorescently-labeled HIV virions and nanoparticles to characterize the structural and adhesive barrier properties of CVM. Our analyses included women with Nugent scores categorized as intermediate (4–6) and BV (7–10), women that were either symptomatic or asymptomatic, and a small group of women before and after antibiotic treatment for symptomatic BV. Overall, we found that HIV virions had significantly increased mobility in CVM from women with BV compared to CVM from women with Lactobacillus crispatus-dominant microbiota, regardless of whether symptoms were present. We confirmed using nanoparticles and scanning electron microscopy that the impaired barrier function was due to reduced adhesive barrier properties without an obvious degradation of the physical CVM pore structure. We further confirmed a similar increase in HIV mobility in CVM from women with Lactobacillus iners-dominant microbiota, the species most associated with transitions to BV and that persists after antibiotic treatment for BV. Our findings advance the understanding of the protective role of mucus and highlight the interplay between vaginal microbiota and the innate barrier function mucus. |
format | Online Article Text |
id | pubmed-6999914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-69999142020-02-18 The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis Hoang, Thuy Toler, Emily DeLong, Kevin Mafunda, Nomfuneko A. Bloom, Seth M. Zierden, Hannah C. Moench, Thomas R. Coleman, Jenell S. Hanes, Justin Kwon, Douglas S. Lai, Samuel K. Cone, Richard A. Ensign, Laura M. PLoS Pathog Research Article Bacterial vaginosis (BV), a condition in which the vaginal microbiota consists of community of obligate and facultative anaerobes rather than dominated by a single species of Lactobacillus, affects ~30% of women in the US. Women with BV are at 60% increased risk for HIV acquisition and are 3-times more likely to transmit HIV to an uninfected partner. As cervicovaginal mucus (CVM) is the first line of defense against mucosal pathogens and the home of the resident vaginal microbiota, we hypothesized the barrier function of CVM to HIV may be diminished in BV. Here, we characterized CVM properties including pH, lactic acid content, and Nugent score to correlate with the microbiota community composition, which was confirmed by 16S rDNA sequencing on a subset of samples. We then quantified the mobility of fluorescently-labeled HIV virions and nanoparticles to characterize the structural and adhesive barrier properties of CVM. Our analyses included women with Nugent scores categorized as intermediate (4–6) and BV (7–10), women that were either symptomatic or asymptomatic, and a small group of women before and after antibiotic treatment for symptomatic BV. Overall, we found that HIV virions had significantly increased mobility in CVM from women with BV compared to CVM from women with Lactobacillus crispatus-dominant microbiota, regardless of whether symptoms were present. We confirmed using nanoparticles and scanning electron microscopy that the impaired barrier function was due to reduced adhesive barrier properties without an obvious degradation of the physical CVM pore structure. We further confirmed a similar increase in HIV mobility in CVM from women with Lactobacillus iners-dominant microbiota, the species most associated with transitions to BV and that persists after antibiotic treatment for BV. Our findings advance the understanding of the protective role of mucus and highlight the interplay between vaginal microbiota and the innate barrier function mucus. Public Library of Science 2020-01-23 /pmc/articles/PMC6999914/ /pubmed/31971984 http://dx.doi.org/10.1371/journal.ppat.1008236 Text en © 2020 Hoang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Hoang, Thuy Toler, Emily DeLong, Kevin Mafunda, Nomfuneko A. Bloom, Seth M. Zierden, Hannah C. Moench, Thomas R. Coleman, Jenell S. Hanes, Justin Kwon, Douglas S. Lai, Samuel K. Cone, Richard A. Ensign, Laura M. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis |
title | The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis |
title_full | The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis |
title_fullStr | The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis |
title_full_unstemmed | The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis |
title_short | The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis |
title_sort | cervicovaginal mucus barrier to hiv-1 is diminished in bacterial vaginosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999914/ https://www.ncbi.nlm.nih.gov/pubmed/31971984 http://dx.doi.org/10.1371/journal.ppat.1008236 |
work_keys_str_mv | AT hoangthuy thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT toleremily thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT delongkevin thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT mafundanomfunekoa thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT bloomsethm thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT zierdenhannahc thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT moenchthomasr thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT colemanjenells thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT hanesjustin thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT kwondouglass thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT laisamuelk thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT conericharda thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT ensignlauram thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT hoangthuy cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT toleremily cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT delongkevin cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT mafundanomfunekoa cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT bloomsethm cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT zierdenhannahc cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT moenchthomasr cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT colemanjenells cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT hanesjustin cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT kwondouglass cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT laisamuelk cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT conericharda cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis AT ensignlauram cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis |